Universitaet Leipzig

Az itteni vizsgálatok

Miről szól a helyszín 273 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Gyermekkori daganatok30 vizsgálat
• Akut mieloid leukémia (AML)21 vizsgálat
• Mielodiszplasztikus szindróma (MDS)17 vizsgálat
• Mielóma multiplex16 vizsgálat
• Fej-nyaki daganatok15 vizsgálat
• Gyomor- és nyelőcsőrák14 vizsgálat
• Sclerosis multiplex (SM)13 vizsgálat
• Vastagbélrák12 vizsgálat
• Akut limfoid leukémia (ALL)11 vizsgálat
• Melanóma11 vizsgálat
• Tüdőrák9 vizsgálat
• Áttétes emlőrák8 vizsgálat
• és még 62

Fázis

• 3. fázis161 vizsgálat
• 2. fázis64 vizsgálat
• 1/2. fázis23 vizsgálat
• 2/3. fázis13 vizsgálat
• 1. fázis9 vizsgálat
• 4. fázis3 vizsgálat

Állapot

• Toboroz109 vizsgálat
• Fut, nem toboroz73 vizsgálat
• Lezárult65 vizsgálat
• Még nem toboroz19 vizsgálat
• Felfüggesztve7 vizsgálat

Fő szponzor

• AstraZeneca15 vizsgálat
• Merck Sharp & Dohme LLC9 vizsgálat
• Janssen Research & Development, LLC8 vizsgálat
• Hoffmann-La Roche7 vizsgálat
• Novartis Pharmaceuticals7 vizsgálat
• és még 147

Futó vizsgálatok

• Még nem toboroz

  A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

  NCT07335562· 3. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás

• Még nem toboroz

  Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

  NCT07291102· 3. fázis· Nationwide Children's Hospital· Forrás

• Még nem toboroz

  Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients - NB2015-LR

  2024-517295-37-00· 3. fázis· University Of Cologne· Forrás

• Toboroz

  Efficacy of Asciminib in Chronic Phase CML Patients With T315I Mutations

  NCT07789574· 2. fázis· Thomas Ernst, Prof. Dr. med.· Forrás

• Még nem toboroz

  A trial to learn how well AZD0120 works and about its safety in adults with transplant eligible newly diagnosed multiple myeloma.

  2026-525367-40-00· 3. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07465289· 3. fázis· UCB Biopharma SRL· Forrás

• Még nem toboroz

  A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

  NCT07719348· 1/2. fázis· Servier· Forrás

• Toboroz

  A trial to learn how well AZD0120 works and how safe it is in people with relapsed or refractory multiple myeloma.

  2025-523285-25-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)

  2025-525016-41-00· 2. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC

  NCT07807163· 2. fázis· Bicara Therapeutics· Forrás

• Még nem toboroz

  AIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia

  2025-522190-11-01· 3. fázis· Universitaetsklinikum Schleswig-Holstein AöR· Forrás

• Még nem toboroz

  Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.

  2026-525883-17-00· 3. fázis· Genmab A/S· Forrás

• Toboroz

  A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  NCT07775300· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  BGB-43395 in Combination with Letrozole versus CDK4/6i with Letrozole for Patients with Previously Untreated Advanced or Metastatic HR+/HER2- Breast Cancer

  NCT07492641· 3. fázis· BeOne Medicines I GmbH· Forrás

• Toboroz

  An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  NCT07665437· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Phase 3 Randomized Study Comparing JNJ-79635322 versus Teclistamab in Participants with Relapsed or Refractory Multiple Myeloma

  2025-523815-12-00· 3. fázis· Janssen Cilag International· Forrás

• Toboroz

  A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT07690371· 3. fázis· Nektar Therapeutics· Forrás

• Toboroz

  Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.

  NCT07843927· 3. fázis· Charite University, Berlin, Germany· Forrás

• Toboroz

  PREFer

  NCT06916416· 2. fázis· University Of Cologne· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07463521· 3. fázis· UCB Biopharma SRL· Forrás

• Még nem toboroz

  A trial to learn how well AZD0120 works and about its safety in adults with newly diagnosed multiple myeloma

  2025-524014-29-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

  NCT07549412· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Fut, nem toboroz

  A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

  2025-522440-41-00· 2. fázis· Bluefin Biomedicine Inc.· Forrás

• Toboroz

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  2025-521546-23-00· 3. fázis· Novartis Pharma AG· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( RAINFOL-03 )

  2024-519818-31-01· 3. fázis· Genmab A/S· Forrás

• Toboroz

  A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

  NCT07355218· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  NCT07299019· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  NCT07067463· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

  NCT07221149· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants

  2025-521762-99-00· 3. fázis· University Medical Center Hamburg-Eppendorf· Forrás

• Toboroz

  A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  NCT07409272· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  NCT07318558· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

  NCT07431281· 3. fázis· AstraZeneca· Forrás

• Toboroz

  Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease

  NCT06875128· 2. fázis· Delcath Systems Inc.· Forrás

• Toboroz

  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  NCT07216703· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  NCT07325292· 3. fázis· Sanofi· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  NCT07221357· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

  NCT07218809· 3. fázis· AstraZeneca· Forrás

• Fut, nem toboroz

  A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis

  NCT07277660· 2. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  Registry and clinical trial comparing standard intensity and reduced intensity treatment in patients with AML or CLL who do not have residual disease.

  2024-512503-39-00· 4. fázis· Medizinische Hochschule Hannover· Forrás

• Toboroz

  STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

  NCT07280585· 3. fázis· University of Cologne· Forrás

• Toboroz

  A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

  NCT07221188· 3. fázis· GlaxoSmithKline· Forrás

• Toboroz

  Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  NCT07222800· 3. fázis· Pfizer· Forrás

• Toboroz

  SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension

  NCT06804161· 3. fázis· Prof. Dr. med. Ingo Eitel· Forrás

• Toboroz

  A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  NCT07276399· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  NCT07211958· 3. fázis· Syndax Pharmaceuticals· Forrás

• Toboroz

  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of ANB033

  2024-520409-38-00· 1. fázis· First Tracks Biotherapeutics Inc.· Forrás

• Toboroz

  A Phase II, Open-Label, Single-Center, Single-Arm Pilot Study to Evaluate the Safety, Tolerability and Efficacy of Blinatumomab for Treatment of Patients with Autoimmune B-Cell driven Diseases including Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc) and Granulomatous Polyangiitis (GPA), BlinA-B trial

  2025-523061-22-00· 2. fázis· Universitaet Leipzig· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

  NCT06804811· 3. fázis· Incyte Corporation· Forrás

Showing 50 of 201.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok15 toboroz
• Akut mieloid leukémia (AML)10 toboroz
• Mielodiszplasztikus szindróma (MDS)8 toboroz
• Mielóma multiplex7 toboroz
• Vastagbélrák7 toboroz
• Fej-nyaki daganatok6 toboroz
• Gyomor- és nyelőcsőrák6 toboroz
• Akut limfoid leukémia (ALL)5 toboroz
• Áttétes emlőrák5 toboroz
• Krónikus mieloid leukémia (CML)5 toboroz
• Méhtestrák5 toboroz
• Petefészekrák5 toboroz
• Tüdőrák5 toboroz
• Hasnyálmirigyrák4 toboroz
• Máj- és epeúti rák4 toboroz
• Méhnyakrák4 toboroz
• Melanóma4 toboroz
• Sclerosis multiplex (SM)4 toboroz
• Depresszió3 toboroz
• Krónikus limfoid leukémia (CLL)3 toboroz
• Lupus (SLE)3 toboroz
• Myasthenia gravis3 toboroz
• Parkinson-kór3 toboroz
• Stroke (szélütés)3 toboroz
• Szarkóma3 toboroz
• Zsírmáj (MASLD/MASH)3 toboroz
• Coeliac disease2 toboroz
• Elhízás2 toboroz
• Glioblasztóma2 toboroz
• Hidradenitis suppurativa2 toboroz
• Mieloproliferatív neopláziák2 toboroz
• Policisztás vesebetegség2 toboroz
• Szisztémás szklerózis (szkleroderma)2 toboroz
• Szívelégtelenség2 toboroz
• Tripla negatív emlőrák2 toboroz
• Alzheimer-kór1 toboroz
• Amiloidózis1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Colitis ulcerosa1 toboroz
• Diabéteszes retinopátia1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Follikuláris limfóma1 toboroz
• HIV-fertőzés1 toboroz
• Hodgkin-limfóma1 toboroz
• Hólyagrák1 toboroz
• Huntington-kór1 toboroz
• Idiopátiás tüdőfibrózis1 toboroz
• Időskori makuladegeneráció1 toboroz
• IgA-nefropátia1 toboroz
• Köpenysejtes limfóma1 toboroz
• Magas vérnyomás1 toboroz
• Mezotelióma1 toboroz
• Myocarditis1 toboroz
• Neuroblasztóma1 toboroz
• Pitvarfibrilláció1 toboroz
• Prosztatarák1 toboroz
• Vascular dementia1 toboroz
• Vesedaganat1 toboroz
• Vitiligo1 toboroz

Lezárt vizsgálatok

• Lezárult

  Essentiale® liquid once-daily Phase III study

  2025-521678-32-00· 3. fázis· Opella Healthcare Group S.A.S.· Forrás

• Fut, nem toboroz

  Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced NSCLC (Substudy NSCLC)

  2024-517818-15-00· 1/2. fázis· Merck Healthcare KGaA· Forrás

• Lezárult

  A Phase 2b Study to Assess the Safety and tolerability of Batoclimab in Patients with CIDP

  2024-518364-12-00· 2. fázis· Immunovant Sciences GmbH· Forrás

• Fut, nem toboroz

  A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

  NCT06422884· 2. fázis· Endeavor Biomedicines, Inc.· Forrás

• Lezárult

  Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

  NCT06433219· 2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Fut, nem toboroz

  RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms

  NCT06243458· 2. fázis· GCP-Service International West GmbH· Forrás

• Lezárult

  A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06335303· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)

  2023-506185-31-00· 2/3. fázis· Pliant Therapeutics Inc.· Forrás

• Lezárult

  Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis

  NCT06430671· 1. fázis· Cellerys AG· Forrás

• Fut, nem toboroz

  Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  NCT06082167· 2/3. fázis· Exelixis· Forrás

• Lezárult

  A study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fallopian tube or primary peritoneal cancers) expressing FOLR1

  NCT05870748· 2. fázis· Sutro Biopharma Inc.· Forrás

• Fut, nem toboroz

  A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

  NCT06346067· 3. fázis· Erasca, Inc.· Forrás

• Lezárult

  Study of IMG-007 in Participants with Moderate to Severe Atopic Dermatitis

  NCT05984784· 1/2. fázis· Inmagene LLC· Forrás

• Lezárult

  A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS).

  NCT05975905· 2. fázis· Keros Therapeutics Inc.· Forrás

• Leállították

  A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis

  NCT06220669· 2. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A Trial to Investigate TransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 β/γ, or Pembrolizumab Monotherapy as Neoadjuvant Therapy in Participants with Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

  2023-506092-10-00· 2. fázis· Ascendis Pharma Oncology Division A/S· Forrás

• Lezárult

  A Phase 3 Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)

  2023-509472-42-00· 3. fázis· Celgene International II S.a.r.l.· Forrás

• Lezárult

  CA-4948-104: A Ph1 Study of Emavusertib in AML CR MRD+ Patients Currently Receiving Azacitidine and Venetoclax

  2023-505828-58-00· 1. fázis· Curis Inc.· Forrás

• Lezárult

  A Study to Evaluate Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants with Relapsed or Refractory Multiple Myeloma

  2023-503689-21-00· 1/2. fázis· F. Hoffmann-La Roche AG· Forrás

• Lezárult

  A MULTICENTER OPEN LABEL 3 MONTH SAFETY STUDY WITH TRADIPITANT IN PATIENTS WITH IDIOPATHIC OR DIABETIC GASTROPARESIS

  2023-503802-35-00· 3. fázis· Vanda Pharmaceuticals Inc.· Forrás

• Lezárult

  A Study to Investigate MBS2320 Patients with IPF

  2023-504418-30-00· 2. fázis· Modern Biosciences Limited· Forrás

• Fut, nem toboroz

  Phase 2 Placebo-controlled Study to Assess the Safety, Efficacy, and PK of ESK-001 in SLE

  2022-502105-15-00· 2. fázis· Alumis Inc.· Forrás

• Lezárult

  Magrolimab plus intensive chemotherapy in newly diagnosed “ELN intermediate or poor-risk” AML patients intended to undergo allogeneic stem cell transplantation, a Phase 2, Single-arm, Open-Label Study (MAGROLIC)

  2022-502040-13-00· 2. fázis· University of Leipzig· Forrás

• Lezárult

  A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

  NCT05923099· 2. fázis· LEO Pharma· Forrás

• Lezárult

  Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

  NCT05882734· 1/2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

  NCT05953480· 2. fázis· Shionogi· Forrás

• Lezárult

  Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP.

  2024-512646-42-00· 2. fázis· Immunovant Sciences GmbH· Forrás

• Leállították

  Hidradenitis Suppurativa Study of Izokibep

  NCT05905783· 3. fázis· ACELYRIN Inc.· Forrás

• Lezárult

  A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05767021· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction

  NCT07304843· 1/2. fázis· Umecrine Cognition AB· Forrás

• Fut, nem toboroz

  Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.

  NCT05201066· 2. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Bayer· Forrás

• Lezárult

  Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN High Risk, Cisplatin-ineligible Participants (XRAY VISION)

  2023-508528-36-00· 3. fázis· Merck Healthcare KGaA· Forrás

• Fut, nem toboroz

  A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

  NCT05567796· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)

  NCT05508867· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Bemarituzumab plus Chemotherapy and Nivolumab versus Chemotherapy and Nivolumab Alone (FORTITUDE-102)

  NCT05111626· 3. fázis· Amgen Inc.· Forrás

• Lezárult

  A Phase 3 Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension (PAH) Patients.

  NCT04811092· 3. fázis· Acceleron Pharma Inc.· Forrás

• Lezárult

  Tiotropium in preventing preschool asthma (TIPP)

  2024-513916-84-00· 3. fázis· Goethe University Frankfurt· Forrás

• Fut, nem toboroz

  A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Inoperable or Metastatic Hormone Receptor-positive, HER2-negative Breast Cancer

  NCT05104866· 3. fázis· AstraZeneca AB· Forrás

• Fut, nem toboroz

  Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

  NCT05182385· 1/2. fázis· Goethe University· Forrás

• Lezárult

  Study to Evaluate the Long-Term Efficacy and Safety of the Investigational Drug LIB003 for the Reduction of Cholesterol in Patients with Homozygous and Heterozygous Familial Hypercholesterolemia, Cardiovascular Disease, or at High Risk for Cardiovascular Disease.

  NCT04798430· 3. fázis· Lib Therapeutics LLC· Forrás

• Lezárult

  An Open-Label, Phase 2 Trial of Nanatinostat in Combination with Valganciclovir in Patients with Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas (NAVAL-1)

  2024-512717-41-00· 2. fázis· Viracta Therapeutics Inc.· Forrás

• Lezárult

  A Long-term Follow-up Study of Sotatercept for PAH Treatment

  NCT04796337· 3. fázis· Acceleron Pharma Inc.· Forrás

• Lezárult

  A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

  NCT04526899· 2. fázis· BioNTech SE· Forrás

• Lezárult

  RegoNivo vs Standard of Care Chemotherapy in AGOC

  NCT04879368· 3. fázis· Australasian Gastro-Intestinal Trials Group· Forrás

• Fut, nem toboroz

  A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

  NCT04486378· 2. fázis· BioNTech SE· Forrás

• Fut, nem toboroz

  A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

  NCT04657991· 3. fázis· Pfizer· Forrás

• Lezárult

  The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC

  NCT04338399· 3. fázis· Adlai Nortye Biopharma Co., Ltd.· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)

  NCT04544436· 3. fázis· Hoffmann-La Roche· Forrás

Showing 50 of 65.